%0 Journal Article
%T Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
%A Abdulrahman Mohammed Al-Amri
%A Ashjan Yousef Bamahfouz
%A Maan A. Albarry
%A Sandra Flavia Fiorentini
%J Archive of "Oman Journal of Ophthalmology".
%D 2017
%R 10.4103/ojo.OJO_232_2014
%X To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC)
%K 0.003% suspension
%K allergy
%K calcineurin inhibitor
%K tacrolimus
%K vernal keratoconjunctivitis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657154/